| Literature DB >> 16552932 |
Abstract
This paper compares the regulation of biotechnology in Britain, Germany and the United States and shows that systematic differences have developed around four issues: abortion, assisted reproduction, stem cells, and genetically modified crops and foods. Policy choices with respect to these issues reflect the capacity of each nation's regulatory institutions to deal with the scientific, social and ethical uncertainties around biotechnology. National regulatory frameworks constitute an apparatus of collective sense-making through which governments and publics interpret biotechnology's risks and promises. Specifically, regulatory choices position the novel ontologies created by biotechnology either on the side of the familiar and manageable or on the side of the unknown and insupportably risky. The comparison shows that public responses to biotechnology are embedded within robust and coherent political cultures and are not ad hoc expressions of concern that very unpredictably from issue to issue.Keywords: Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach
Mesh:
Year: 2005 PMID: 16552932 DOI: 10.1080/14636770500190864
Source DB: PubMed Journal: New Genet Soc ISSN: 1463-6778